Patrick Burnett's Insider Trades & SAST Disclosures
Patrick Burnett's most recent trade in Arcutis Biotherapeutics Inc was a trade of 44,153 Common Stock done at an average price of $15.0 . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick Burnett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 14.97 per share. | 13 Mar 2025 | 44,153 | 121,936 (0%) | 0% | 15.0 | 660,772 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 12,242 | 201,250 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 13 Mar 2025 | 12,242 | 121,936 (0%) | 0% | 15.0 | 184,107 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 12,242 | 134,178 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 5,008 | 213,492 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 13 Mar 2025 | 5,008 | 121,936 (0%) | 0% | 15.1 | 75,631 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 5,008 | 126,944 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99,000 | 99,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 43,000 | 43,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 38,000 | 152,862 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 17,000 | 169,862 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 28 Feb 2025 | 2,819 | 167,043 (0%) | 0% | 13.0 | 36,735 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 28 Feb 2025 | 954 | 166,089 (0%) | 0% | 13.3 | 12,673 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 03 Feb 2025 | 12,116 | 114,862 (0%) | 0% | 12.7 | 153,873 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 31 Dec 2024 | 1,691 | 126,978 (0%) | 0% | 14 | 23,674 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 16,023 | 144,692 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 22 Nov 2024 | 16,023 | 128,669 (0%) | 0% | 10.1 | 162,515 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 16,023 | 218,500 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 14 Nov 2024 | 50,749 | 128,669 (0%) | 0% | 10.3 | 522,436 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 18,377 | 234,623 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 14 Nov 2024 | 18,377 | 128,669 (0%) | 0% | 10.3 | 189,182 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 18,377 | 147,046 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 100 | 234,523 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 14 Nov 2024 | 100 | 128,669 (0%) | 0% | 10.0 | 1,003 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 100 | 128,769 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 8.68 per share. | 04 Nov 2024 | 15,441 | 179,418 (0%) | 0% | 8.7 | 134,093 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 8.29 per share. | 19 Aug 2024 | 1,728 | 194,859 (0%) | 0% | 8.3 | 14,318 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 02 Aug 2024 | 13,206 | 196,587 (0%) | 0% | 9.0 | 119,106 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 8.72 per share. | 29 May 2024 | 49,952 | 209,793 (0%) | 0% | 8.7 | 435,387 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 23,000 | 253,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 23,000 | 232,793 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 29 May 2024 | 23,000 | 209,793 (0%) | 0% | 8.8 | 201,319 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 02 May 2024 | 9,555 | 259,745 (0%) | 0% | 8.7 | 83,490 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 11.12 per share. | 04 Mar 2024 | 4,782 | 269,300 (0%) | 0% | 11.1 | 53,182 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 320,000 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 128,000 | 213,032 (0%) | 0% | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 55,800 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 47,100 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Burnett Patrick | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 28,800 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 27,900 | 274,082 (0%) | 0% | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,550 | 246,182 (0%) | 0% | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 9,600 | 222,632 (0%) | 0% | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 276,000 | 276,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Burnett Patrick | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 28,000 | 85,032 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Burnett Patrick | See Remarks | Sale of securities on an exchange or to another person at price $ 3.54 per share. | 02 Jan 2024 | 1,325 | 57,032 (0%) | 0% | 3.5 | 4,692 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 18 Aug 2023 | 1,305 | 58,357 (0%) | 0% | 7.0 | 9,187 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 7.05 per share. | 18 Aug 2023 | 300 | 59,662 (0%) | 0% | 7.1 | 2,115 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 06 Mar 2023 | 851 | 59,962 (0%) | 0% | 15.3 | 12,989 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 55,800 | 55,800 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 21,000 | 60,813 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 02 Mar 2023 | 1,728 | 39,836 (0%) | 0% | 15.8 | 27,333 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 02 Mar 2023 | 23 | 39,813 (0%) | 0% | 16.5 | 380 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 03 Jan 2023 | 1,475 | 41,564 (0%) | 0% | 15.0 | 22,136 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 47,100 | 47,100 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 17,800 | 44,050 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 16.86 per share. | 03 Mar 2022 | 981 | 43,069 (0%) | 0% | 16.9 | 16,539 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 16.43 per share. | 03 Mar 2022 | 30 | 43,039 (0%) | 0% | 16.4 | 493 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 28,800 | 28,800 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 9,500 | 9,500 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 33,500 | 33,500 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges